| James Reed Gahagan, DO | |
|
4929 Mobile Hwy, Pensacola, FL 32506-3229 | |
| (850) 453-3281 | |
| (850) 453-4491 |
| Full Name | James Reed Gahagan |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 4929 Mobile Hwy, Pensacola, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063733368 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS11894 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Suncrest Omni | Pensacola, FL | Home health agency |
| Kindred At Home | Pensacola, FL | Home health agency |
| Amedisys Home Health | Pensacola, FL | Home health agency |
| Peoples Home Health Llc | Pensacola, FL | Home health agency |
| Sacred Heart Hospital | Pensacola, FL | Hospital |
| Baptist Hospital | Pensacola, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sacred Heart Health System Inc | 3779491386 | 355 |
News Archive
A study led by University of Pennsylvania School of Medicine researchers has, for the first time, determined access to trauma centers at the national level.
In a new study, researchers have developed updated guidelines for classifying a serious form of skin cancer called invasive melanoma. The American Joint Committee on Cancer, an organization that provides information on "cancer staging," or the severity of individual cases of cancer, recently updated its guidelines for melanoma.
PharmaVentures Ltd announced today that it had acted as the advisor and broker to the Indian pharmaceutical company Dr Reddy's Laboratories in its successful marketing and distribution agreement with the UK healthcare company Vitabiotics Ltd for a range of nutraceutical products. The agreement provides Dr Reddy's exclusive marketing rights in the Russian/CIS markets for two of Vitabiotics' leading products - Jointace and Dietrim. Vitabiotics will supply these products on a long-term basis from its facilities in Europe.
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health. The experimental agent, known as AR-42 while in testing, was developed and tested in preclinical studies at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
"SHE" - Strong, HIV Positive, Empowered Women - the first comprehensive European patient education programme to address the growing challenges faced by women living with HIV, was launched at the 6th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Rome, Italy.
› Verified 3 days ago
| Entity Name | Sacred Heart Health System, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770533077 PECOS PAC ID: 0244126621 Enrollment ID: O20040224000019 |
News Archive
A study led by University of Pennsylvania School of Medicine researchers has, for the first time, determined access to trauma centers at the national level.
In a new study, researchers have developed updated guidelines for classifying a serious form of skin cancer called invasive melanoma. The American Joint Committee on Cancer, an organization that provides information on "cancer staging," or the severity of individual cases of cancer, recently updated its guidelines for melanoma.
PharmaVentures Ltd announced today that it had acted as the advisor and broker to the Indian pharmaceutical company Dr Reddy's Laboratories in its successful marketing and distribution agreement with the UK healthcare company Vitabiotics Ltd for a range of nutraceutical products. The agreement provides Dr Reddy's exclusive marketing rights in the Russian/CIS markets for two of Vitabiotics' leading products - Jointace and Dietrim. Vitabiotics will supply these products on a long-term basis from its facilities in Europe.
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health. The experimental agent, known as AR-42 while in testing, was developed and tested in preclinical studies at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
"SHE" - Strong, HIV Positive, Empowered Women - the first comprehensive European patient education programme to address the growing challenges faced by women living with HIV, was launched at the 6th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Rome, Italy.
› Verified 3 days ago
| Entity Name | Sacred Heart Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962453308 PECOS PAC ID: 3779491386 Enrollment ID: O20051015000049 |
News Archive
A study led by University of Pennsylvania School of Medicine researchers has, for the first time, determined access to trauma centers at the national level.
In a new study, researchers have developed updated guidelines for classifying a serious form of skin cancer called invasive melanoma. The American Joint Committee on Cancer, an organization that provides information on "cancer staging," or the severity of individual cases of cancer, recently updated its guidelines for melanoma.
PharmaVentures Ltd announced today that it had acted as the advisor and broker to the Indian pharmaceutical company Dr Reddy's Laboratories in its successful marketing and distribution agreement with the UK healthcare company Vitabiotics Ltd for a range of nutraceutical products. The agreement provides Dr Reddy's exclusive marketing rights in the Russian/CIS markets for two of Vitabiotics' leading products - Jointace and Dietrim. Vitabiotics will supply these products on a long-term basis from its facilities in Europe.
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health. The experimental agent, known as AR-42 while in testing, was developed and tested in preclinical studies at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
"SHE" - Strong, HIV Positive, Empowered Women - the first comprehensive European patient education programme to address the growing challenges faced by women living with HIV, was launched at the 6th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Rome, Italy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Reed Gahagan, DO Po Box 2699, Pensacola, FL 32513-2699 Ph: (850) 453-3281 | James Reed Gahagan, DO 4929 Mobile Hwy, Pensacola, FL 32506-3229 Ph: (850) 453-3281 |
News Archive
A study led by University of Pennsylvania School of Medicine researchers has, for the first time, determined access to trauma centers at the national level.
In a new study, researchers have developed updated guidelines for classifying a serious form of skin cancer called invasive melanoma. The American Joint Committee on Cancer, an organization that provides information on "cancer staging," or the severity of individual cases of cancer, recently updated its guidelines for melanoma.
PharmaVentures Ltd announced today that it had acted as the advisor and broker to the Indian pharmaceutical company Dr Reddy's Laboratories in its successful marketing and distribution agreement with the UK healthcare company Vitabiotics Ltd for a range of nutraceutical products. The agreement provides Dr Reddy's exclusive marketing rights in the Russian/CIS markets for two of Vitabiotics' leading products - Jointace and Dietrim. Vitabiotics will supply these products on a long-term basis from its facilities in Europe.
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health. The experimental agent, known as AR-42 while in testing, was developed and tested in preclinical studies at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
"SHE" - Strong, HIV Positive, Empowered Women - the first comprehensive European patient education programme to address the growing challenges faced by women living with HIV, was launched at the 6th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Rome, Italy.
› Verified 3 days ago
Kristopher Ward Randall, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 220 Hovey Rd, Pensacola, FL 32508 Phone: 850-452-2933 | |
Wayne S Willis, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3111 Peggy Bond Dr, Pensacola, FL 32504 Phone: 850-438-9755 Fax: 850-438-0699 | |
Dr. Kyle Harvey, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 220 Hovey Rd, Pensacola, FL 32508 Phone: 770-396-3898 | |
Alisha Dalila Carter, NP-BC Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 45 Industrial Blvd Ste C, Pensacola, FL 32503 Phone: 850-290-8410 Fax: 866-574-6391 | |
Mr. David R Smith, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 321 S Fairfield Dr, Pensacola, FL 32506 Phone: 850-458-4200 Fax: 850-456-7222 | |
Dr. Roberta Beals, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4724 N Davis Hwy, Pensacola, FL 32503 Phone: 850-696-4000 Fax: 850-434-2647 | |
Mr. Christopher H Rush, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 321 S Fairfield Dr, Pensacola, FL 32506 Phone: 850-474-8546 Fax: 850-456-7222 |